-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| Expert: The prevention and control rate of bivalent HPV vaccine reaches 84. China News Service, Guangzhou, July 18 (Cai Minjie and He Yuhang) The current cervical cancer vaccines include domestically produced two-valent, imported two-valent, four-valent, and nine-valent vaccines Wang Ming, chief expert of the Guangzhou Preventive Medicine Association, participated in the "Cervical Cancer and Hepatitis E Disease Prevention and Control Strategy Symposium" held in Guangzhou on the 18th, said that HPV (papilloma virus) 16 and HPV 18 are the two types with the highest risk. Human papillomavirus is abbreviated as HPV, which is the main cause of cervical cancer Cervical cancer is the fourth leading malignant tumor for women in the world and the largest gynecological malignant tumor in the Mainland In 2018, the World Health Organization called for the global elimination of cervical cancer. Cervical cancer is preventable and controllable and requires early vaccination and early protection Currently, China is the only country in the world that has four HPV vaccines on the market Studies have shown that more than 84. "Bivalent vaccines mainly prevent two high-risk subtypes, 16 and 18, and can be vaccinated for people aged 9 to 45. In December 2019, the National Medical Products Administration approved Xiamen Wantai Biotech's bivalent human papillomavirus vaccine to be marketed This is the first domestically approved HPV vaccine for women between 9 and 45 years old Wang Ming said that cervical cancer is currently the only malignant tumor with a clear etiology, preventable and controllable. (Finish)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
Welcome to ECHEMI 
|
